HIF-2α is a driver of ccRCC oncogenesis and acquisition of the clear-cell morphology39,40, and its emergence as a ferroptosis regulator is consistent with a prior study revealing that VHL-restoration diminished the sensitivity to erastin and BSO in RCC4, another ccRCC cell line14. The gene discussed is EPAS1; the disease is nonpapillary renal cell carcinoma.